Barrington Maintains SurModics(SRDX.US) With Hold Rating
Surmodics Analyst Ratings
Needham Maintains SurModics(SRDX.US) With Hold Rating
Barrington Maintains SurModics(SRDX.US) With Hold Rating
Surmodics Analyst Ratings
Needham Maintains SurModics(SRDX.US) With Hold Rating
Barrington Maintains SurModics(SRDX.US) With Hold Rating
SurModics Holds Steady Amid Acquisition Uncertainty: A Market Perform Rating
Lake Street Maintains SurModics(SRDX.US) With Hold Rating, Maintains Target Price $43
SurModics (SRDX) Receives a Hold From Lake Street
SurModics (SRDX) Was Downgraded to a Hold Rating at Barrington
Surmodics Analyst Ratings
SurModics (SRDX) Was Downgraded to a Hold Rating at Needham
SurModics (SRDX) Gets a Buy From Lake Street
Analysts Are Bullish on These Healthcare Stocks: Assertio Therapeutics (ASRT), SurModics (SRDX)
Surmodics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and SurModics (SRDX)
Surmodics Analyst Ratings
SurModics Outperforms With Raised Guidance and Strong Product Momentum: Buy Rating Reaffirmed
Analysts Offer Insights on Healthcare Companies: SurModics (SRDX) and Pfizer (PFE)